Attorneys are investigating whether certain supplement makers made false claims about the benefits of their elderberry products or otherwise violated federal labeling requirements.
Defective Drugs and Supplements
When pharmaceutical companies release dangerous and defective drugs into the marketplace, patients who are injured as a result may be able to take legal action. Typically, these lawsuits allege that a pharmaceutical company made a drug that was somehow defective – either in design, manufacturing or marketing. A drug suffers from a marketing defect if the company failed to properly warn patients or doctors about a certain side effect.
It’s important to note that most lawsuits involving pharmaceutical drugs aren’t class action lawsuits, but rather individual lawsuits filed by one person with the help of his or her attorney. (You can find out why drug lawsuits aren’t suited for class action litigation by reading this article.)
If you’ve been injured by any of the drugs listed below, get in touch with us today by filling out this form. There’s no cost or obligation to contact us or to talk to an attorney about whether you can file a lawsuit.
Sign Up For
New cases and investigations, settlement deadlines, and news straight to your inbox.
Lawsuits are now being filed on behalf of Elmiron patients who suffered permanent retinal injuries and seek to recover money for physical and mental anguish, medical expenses and more. The suits allege that the drug is defective and unreasonably dangerous and was not adequately labeled to warn both patients and doctors of its risks.
Some health insurance companies may be purposely delaying coverage of Harvoni until the patient has reached later stages of hepatitis C in the hopes he or she will die or switch insurers before the company has to pay for the drug.
Attorneys are investigating whether a class action lawsuit can be filed against the maker of Neuriva, challenging the claims that the brain supplement is clinically proven and scientifically backed.
The manufacturers of proton pump inhibitors (PPIs) are being sued by patients who were diagnosed with certain types of kidney injuries.
It is believed some health insurance companies are wrongfully denying coverage for this treatment despite overwhelming evidence of its efficacy and ongoing support from the medical community.
Women across the country have filed lawsuits against Johnson & Johnson alleging that the company's talcum powders can cause ovarian cancer when used near the genitals.
Class action lawsuits have been filed alleging that Zantac exposes users to unsafe levels of a probable carcinogen and that the manufacturers knew about the risk but failed to disclose it.